|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 |
| (11) | Patento numeris | 2989125 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14718115.0 |
| Europos patento paraiškos padavimo data | 2014-04-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/057909 |
| Data | 2014-04-17 |
| (87) | Numeris | WO 2014/173814 |
| Data | 2014-10-30 |
| (30) | Numeris | Data | Šalis |
| 13164695 | 2013-04-22 | EP |
| (72) |
HOVES, Sabine, DE
RIES, Carola, DE
RUETTINGER, Dominik, DE
WARTHA, Katharina, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST |
| COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST |